Published in Postgrad Med J on January 01, 1985
Effects of amiodarone during pregnancy. CMAJ (1987) 0.75
Amiodarone therapy during pregnancy. Am J Cardiol (1983) 1.35
High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: methodology and preliminary observations. Ther Drug Monit (1982) 1.31
Amiodarone in pregnancy. Lancet (1983) 1.11
High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion. J Clin Pathol (1983) 1.00
Side effects of long-term amiodarone therapy. Circulation (1983) 3.03
Fatal overdosage with disopyramide. Lancet (1978) 2.96
Smoking and decreased fertilisation rates in vitro. Lancet (1992) 2.92
Purchasing 'legal highs' on the Internet--is there consistency in what you get? QJM (2010) 2.43
Amiodarone pharmacokinetics. Am Heart J (1983) 2.42
Comparison of two strategies for myocardial management during coronary artery operations. Ann Thorac Surg (1994) 2.21
Measuring brain natriuretic peptide. Lancet (1996) 2.03
Evaluation of fetal arrhythmias by echocardiography. Br Heart J (1983) 1.59
Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J (2001) 1.54
Simple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine. Ther Drug Monit (1997) 1.48
TGF-beta quantitation can be tricky. Transplantation (1999) 1.47
A controlled trial of substrate-enhanced, warm reperfusion ("hot shot") versus simple reperfusion. Ann Thorac Surg (2000) 1.38
The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med (2009) 1.36
High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: methodology and preliminary observations. Ther Drug Monit (1982) 1.31
Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum. J Chromatogr (1981) 1.26
Paediatric use of mexiletine and disopyramide. Br Med J (1979) 1.23
Amiodarone in testis and semen. Lancet (1985) 1.20
Buying 'legal' recreational drugs does not mean that you are not breaking the law. QJM (2010) 1.19
Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit (2001) 1.17
Death rate from use of ecstasy or heroin. Lancet (2000) 1.12
Amiodarone in pregnancy. Lancet (1983) 1.11
Neuropathy and fatal hepatitis in a patient receiving amiodarone. Br Med J (Clin Res Ed) (1984) 1.11
Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation (1985) 1.07
Postmortem assay of digoxin by radioimmunoassay. J Clin Pathol (1975) 1.06
Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). QJM (2008) 1.05
Rapid high-performance liquid chromatographic method for the measurement of amiodarone in blood plasma or serum at the concentrations attained during therapy. J Chromatogr (1980) 1.02
Amiodarone pharmacokinetics. Br J Clin Pract Suppl (1986) 1.02
Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem (1998) 1.01
Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J (1995) 1.01
High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion. J Clin Pathol (1983) 1.00
Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals. Clin Chim Acta (2001) 0.99
Accuracy of cyclosporin measurements made in capillary blood samples obtained by skin puncture. Ther Drug Monit (2000) 0.98
Intravenous and oral amiodarone for arrhythmias in children. Br Heart J (1986) 0.98
HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimus. Clin Chem (2001) 0.97
Lack of response to intravenous calcium in severe verapamil poisoning. Lancet (1982) 0.97
An immunoassay for the measurement of sirolimus. Clin Ther (2000) 0.96
Mexiletine for control of ventricular dysrhythmias in pregnancy. Lancet (1980) 0.96
The United Kingdom Cyclosporin Quality Assessment Scheme. Ther Drug Monit (1986) 0.96
Identification and measurement of desethylamiodarone in blood plasma specimens from amiodarone-treated patients. J Pharm Pharmacol (1982) 0.95
The pathogenesis of amiodarone-induced pigmentation and photosensitivity. Br J Dermatol (1984) 0.95
Peripheral neutrophil inclusions in amiodarone treated patients. Br J Clin Pharmacol (1986) 0.95
A new method to monitor drugs at dance venues. BMJ (2001) 0.93
Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit (1995) 0.92
Cyclosporine blood concentrations in the management of renal transplant recipients. Transplantation (1986) 0.92
Measurement of cyclosporine: methodological problems. Transplant Proc (1986) 0.91
High-performance liquid chromatographic measurement of atenolol: methodology and clinical applications. Ther Drug Monit (1983) 0.91
Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure. Kidney Int (2000) 0.91
Simple gas-liquid chromatographic method for the measurement of mexiletine and lignocaine in blood-plasma or serum. J Chromatogr (1979) 0.90
Effect of age and plasma concentrations of albumin and alpha 1-acid glycoprotein on protein binding of disopyramide. Br J Clin Pharmacol (1983) 0.89
Neuropsychological change and S-100 protein release in 130 unselected patients undergoing cardiac surgery. Stroke (1999) 0.89
Measurement of the end-diastolic pressure gradient and mitral valve area in mitral stenosis by Doppler ultrasound. Eur Heart J (1984) 0.87
Serum neopterin in acute coronary syndromes. Lancet (1997) 0.87
Hepatic effects of amiodarone. Br J Clin Pract Suppl (1986) 0.86
The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. Br J Clin Pract (1985) 0.86
Bioavailability of amiodarone. Eur J Clin Pharmacol (1984) 0.86
Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection. J Antimicrob Chemother (2010) 0.86
Gas-liquid chromatographic measurement of lignocaine in small samples of canine myocardium after enzymatic digestion. J Clin Pathol (1979) 0.85
Current opinions on therapeutic drug monitoring of immunosuppressive drugs. Clin Ther (1999) 0.85
Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation. Eur Heart J (1997) 0.85
Circulating cardiac troponin-T in patients before and after renal transplantation. Clin Chim Acta (2001) 0.84
High-performance liquid chromatographic method for the measurement of mexiletine and flecainide in blood plasma or serum. J Chromatogr (1984) 0.84
Therapeutic drug monitoring of cyclosporine. Transplant Proc (2004) 0.84
A limited sampling strategy for the measurement of cyclosporine AUC. Transplant Proc (1990) 0.84
Blood cyclosporin concentrations and renal allograft dysfunction. Br Med J (Clin Res Ed) (1986) 0.84
Concentration-controlled trials. What does the future hold? Clin Pharmacokinet (1995) 0.84
Plasma disopyramide concentrations following a 300-mg oral loading dose in acute myocardial infarction. Ther Drug Monit (1982) 0.83
Mycophenolate mofetil: a report of the consensus panel. Ther Drug Monit (1995) 0.83
Creatine kinase MB isoforms: sensitive markers of ischemic myocardial damage. Clin Chem (1994) 0.83
Therapeutic drug monitoring of immunosuppressant drugs. Br J Clin Pharmacol (1999) 0.83
Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics. Br Heart J (1989) 0.83
Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients. Intensive Care Med (2011) 0.82
High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in plasma or serum at the concentrations attained following a single 400-mg dose. J Chromatogr (1982) 0.82
Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage. Br Heart J (1985) 0.82
Experience with flecainide for the treatment of cardiac arrhythmias in children. Eur Heart J (1988) 0.82
Experimental disopyramide poisoning: treatment by cardiovascular support and with charcoal hemoperfusion. J Pharmacol Exp Ther (1979) 0.81
Osteoarthritis in temporomandibular joint of Col2a1 mutant mice. Arch Oral Biol (2013) 0.81
Immunosuppressant drugs--the role of therapeutic drug monitoring. Br J Clin Pharmacol (2001) 0.81
Cardiac troponin T and creatine kinase MB are not increased in exterior oblique muscle of patients with renal failure. Clin Chem (2001) 0.81
Cardiac consequences and treatment of disopyramide intoxication: experimental evaluation in dogs. Cardiovasc Res (1979) 0.81
The effect of vehicle on the oral absorption of cyclosporin. Br J Clin Pharmacol (1986) 0.81
The digoxin-amiodarone interaction. Cardiovasc Drugs Ther (1989) 0.81
Myocardial injury induced by radiofrequency and low energy ablation: a quantitative study of CK isoforms, CK-MB, and troponin-T concentrations. Pacing Clin Electrophysiol (1998) 0.81
Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis. Eur J Heart Fail (2001) 0.80
Optimizing the use of cyclosporine in renal transplantation. Clin Biochem (1995) 0.80
Treatment of disopyramide overdosage. Med J Aust (1979) 0.80
Which cyclosporin formulation? Lancet (1996) 0.79
Electrophysiological properties of mexiletine assessed with respect to plasma concentrations. Eur J Cardiol (1980) 0.79
Can vacuum assisted venous drainage be achieved using a roller pump in an emergency? A pilot study using neonatal circuitry. J Extra Corpor Technol (2007) 0.79